These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3046059

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Urinary C-peptide as an index of unstable glycemic control in insulin-dependent diabetes mellitus (IDDM).
    Cha T, Tahara Y, Ikegami H, Fukuda M, Yoneda H, Yamato E, Yamamoto Y, Noma Y, Shima K, Ogihara T.
    Diabetes Res Clin Pract; 1991 Sep; 13(3):181-7. PubMed ID: 1959481
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [Abstract] [Full Text] [Related]

  • 7. Residual beta-cell function and HLA-A24 in IDDM. Markers of glycemic control and subsequent development of diabetic retinopathy.
    Nakanishi K, Kobayashi T, Inoko H, Tsuji K, Murase T, Kosaka K.
    Diabetes; 1995 Nov; 44(11):1334-9. PubMed ID: 7589833
    [Abstract] [Full Text] [Related]

  • 8. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
    Nakanishi K, Kobayashi T, Miyashita H, Ohkubo M, Sugimoto T, Murase T, Kosaka K, Inouye K, Kono M.
    Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L, Korányi L, Tamás G.
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [Abstract] [Full Text] [Related]

  • 14. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
    Hsieh SD, Iwamoto Y, Matsuda A, Kuzuya T.
    Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
    [Abstract] [Full Text] [Related]

  • 15. High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.
    Schnell O, Eisfelder B, Standl E, Ziegler AG.
    Diabetes; 1997 Oct; 46(10):1607-11. PubMed ID: 9313757
    [Abstract] [Full Text] [Related]

  • 16. Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve.
    Clarson C, Daneman D, Drash AL, Becker DJ, Ehrlich RM.
    Diabetes Care; 1987 Oct; 10(1):33-8. PubMed ID: 3552512
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urine C-peptide, beta-cell function, and insulin requirement.
    Rappaport EB, Ulstrom RA, Etzwiler DD, Fife D, Hedlund BE, Steffes MW.
    Am J Dis Child; 1980 Dec; 134(12):1129-33. PubMed ID: 7004175
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.